Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma
Open Access
- 31 May 2007
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (5), 594-600
- https://doi.org/10.1016/j.bbmt.2007.01.072
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory hodgkin disease: A southwest oncology group phase II trialTransplantation and Cellular Therapy, 2003
- Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)Bone Marrow Transplantation, 2001
- Problems in Hodgkin’s Disease ManagementBlood, 1999
- Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.Journal of Clinical Oncology, 1997
- High-Dose Therapy and Autologous Hematopoietic Progenitor Cell Transplantation for Recurrent or Refractory Hodgkin's Disease: Analysis of the Stanford University Results and Prognostic IndicesBlood, 1997
- High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsBlood, 1995
- Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]Blood, 1994
- Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.Journal of Clinical Oncology, 1992
- Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.Journal of Clinical Oncology, 1990
- High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.Journal of Clinical Oncology, 1990